Accendra Health Inc (ACH) Income Statement
ACH 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsACH revenue and net income
Where ACH's revenue goes
2025Each bar shows an amount and its share of revenue. ACH kept −39.8% of revenue as net income.
ACH profit margins
ACH growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −74.2% | −34.8% | −20.1% | −11.9% |
| Gross profit | −41.9% | −11.0% | +0.1% | +0.6% |
| Operating income | — | +15.8% | +1.7% | +1.0% |
| Net income | — | — | — | — |
| EPS (diluted) | — | +1.4% | −9.3% | −7.2% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
ACH quarterly EPS vs estimates
Accendra Health beat the analyst EPS estimate in 4 of the last 7 quarters. Next report: October 29, 2026 (estimate $-0.04).
ACH income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.76B | $10.70B | $10.33B | $9.96B | $9.79B | $8.48B | $9.21B | $9.42B | $9.32B | $9.72B |
| Cost of revenue | $1.47B | $8.48B | $8.21B | $8.13B | $8.27B | $7.20B | $8.08B | $8.35B | $8.15B | $8.54B |
| Gross profit | $1.29B | $2.22B | $2.13B | $1.83B | $1.51B | $1.28B | $1.13B | $1.07B | $1.17B | $1.19B |
| Research & development | — | — | — | — | $12.1M | — | — | — | — | — |
| Sales, general & admin | $1.07B | $1.91B | $1.81B | $1.55B | $1.08B | $1.04B | $1.02B | $1.26B | $1.02B | $970.4M |
| Total operating expenses | $1.07B | $2.43B | $2.02B | $1.68B | $1.14B | $1.08B | $1.06B | $1.42B | $1.08B | $987.7M |
| Operating income | $221.7M | −$207.8M | $104.5M | $142.9M | $368.5M | $204.1M | $73.2M | −$352.3M | $89.3M | $199.6M |
| Interest income | $107.2M | $143.8M | $157.9M | $128.9M | — | — | — | — | — | — |
| Interest expense | $107.2M | $143.8M | $157.9M | $128.9M | $48.1M | $83.4M | $98.1M | $71.0M | $31.8M | $27.1M |
| Income before taxes | −$102.0M | −$357.4M | −$54.7M | $10.9M | $276.8M | $109.9M | −$28.7M | −$427.1M | $57.5M | $172.5M |
| Income taxes | $729,000 | $5.3M | −$13.4M | −$11.5M | $55.2M | $21.8M | −$6.1M | $32.4M | −$15.3M | $63.8M |
| Net income | −$1.10B | −$362.7M | −$41.3M | $22.4M | $221.6M | $29.9M | −$62.4M | −$437.0M | $72.8M | $108.8M |
| EBITDA | $219.8M | $51.2M | $390.6M | $368.4M | $415.5M | $323.4M | $186.7M | −$272.7M | $209.4M | $279.7M |
| EPS (diluted) | $0.95 | −$2.87 | $0.90 | $0.91 | $4.18 | $1.55 | $0.56 | −$3.30 | $1.59 | $2.05 |
| Gross margin | 46.7% | 20.7% | 20.6% | 18.3% | 15.5% | 15.1% | 12.3% | 11.4% | 12.6% | 12.2% |
| Operating margin | 8.0% | −1.9% | 1.0% | 1.4% | 3.8% | 2.4% | 0.8% | −3.7% | 1.0% | 2.1% |
| Net margin | −39.8% | −3.4% | −0.4% | 0.2% | 2.3% | 0.4% | −0.7% | −4.6% | 0.8% | 1.1% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $613.2M | $627.8M | $709.0M | $697.3M | $681.9M | $2.63B | $2.70B | $686.8M | $660.4M | $2.61B | $2.66B | $2.59B |
| Cost of revenue | $349.8M | $349.8M | $385.7M | $375.1M | $357.3M | $2.11B | $2.12B | $355.1M | $344.4M | $2.08B | $2.09B | $2.05B |
| Gross profit | $263.4M | $278.0M | $323.3M | $322.2M | $324.6M | $526.0M | $579.8M | $331.8M | $316.0M | $535.5M | $569.9M | $538.5M |
| Research & development | — | — | — | — | — | — | — | — | — | — | $13.2M | — |
| Sales, general & admin | $243.6M | $255.2M | $271.5M | $265.8M | $267.9M | $462.4M | $101.4M | $197.5M | $469.3M | $477.6M | $1.81B | $452.6M |
| Total operating expenses | $298.6M | $255.2M | $271.5M | $265.8M | $267.9M | $525.9M | $841.7M | $300.7M | $299.1M | $525.8M | $509.9M | $514.7M |
| Operating income | −$35.1M | $22.8M | $51.8M | $56.4M | $56.7M | $124,000 | −$262.0M | $31.1M | $16.9M | $9.7M | $60.0M | $23.8M |
| Interest income | — | — | $27.9M | $29.0M | $26.0M | $34.0M | — | — | — | — | — | — |
| Interest expense | $34.5M | $32.3M | $27.9M | $29.0M | $26.0M | $34.0M | $35.7M | $36.6M | $35.9M | $35.7M | $36.9M | $38.1M |
| Income before taxes | −$87.6M | −$16.2M | −$8.0M | −$3.6M | −$84.9M | −$35.1M | −$299.7M | $958,000 | −$9.5M | −$27.1M | $21.0M | −$11.0M |
| Income taxes | $1.4M | −$9.8M | $1.5M | $2.0M | −$1.1M | −$10.1M | −$3.5M | −$303,000 | −$2.7M | −$5.2M | $3.2M | −$4.6M |
| Net income | −$89.1M | −$6.5M | −$56.3M | −$150.3M | −$869.1M | −$25.0M | −$296.1M | −$12.8M | −$31.9M | −$21.9M | $17.8M | −$6.4M |
| EBITDA | $12.6M | $77.8M | $49.8M | $89.5M | $18.7M | $60.0M | −$198.8M | $91.5M | $80.0M | $82.6M | $158.4M | $100.8M |
| EPS (diluted) | −$0.19 | −$0.04 | $0.21 | $0.25 | $0.26 | $0.23 | −$3.84 | $0.42 | $0.36 | $0.19 | $0.23 | $0.44 |
| Gross margin | 43.0% | 44.3% | 45.6% | 46.2% | 47.6% | 20.0% | 21.5% | 48.3% | 47.9% | 20.5% | 21.5% | 20.8% |
| Operating margin | −5.7% | 3.6% | 7.3% | 8.1% | 8.3% | 0.0% | −9.7% | 4.5% | 2.6% | 0.4% | 2.3% | 0.9% |
| Net margin | −14.5% | −1.0% | −7.9% | −21.6% | −127.4% | −0.9% | −11.0% | −1.9% | −4.8% | −0.8% | 0.7% | −0.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in ACH's financial statements (latest annual report filed February 20, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
ACH financial results
In fiscal year 2025 (ended December 31, 2025), Accendra Health reported revenue of $2.8 billion, down 74.2% from the year before. It had a net loss of $1.1 billion, a net profit margin of −39.8%. Diluted earnings per share came to $0.95. Over five years revenue grew at an average rate of −20.1% a year.
See the ACH stock overview for the latest quote and news, or the ACH chart for price history and technical indicators.
ACH income statement FAQ
What is Accendra Health's annual revenue?
Accendra Health reported total revenue of $2.8 billion for fiscal year 2025, which ended on December 31, 2025. That was down 74.2% from $10.7 billion the previous year.
Is Accendra Health profitable?
No. Accendra Health reported a net loss of $1.1 billion in fiscal 2025, a net profit margin of −39.8%; its operating margin was 8.0%.
What is Accendra Health's gross margin?
Accendra Health's gross margin was 46.7% in fiscal 2025: for every $100 of revenue, Accendra Health kept $47 after the direct cost of its products and services.
How fast is Accendra Health growing?
Revenue grew −20.1% a year on average over the last five fiscal years, from $8.5 billion to $2.8 billion.
What are Accendra Health's earnings per share?
Accendra Health earned $0.95 per diluted share in fiscal 2025, compared with $-2.87 a year earlier.
When will Accendra Health report its next earnings?
Accendra Health is expected to report results for the quarter ending September 30, 2026 on October 29, 2026 before the market opens.
When does Accendra Health's fiscal year end?
Accendra Health's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 20, 2026.